These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 17030350
1. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R. Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350 [Abstract] [Full Text] [Related]
2. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R. Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315 [Abstract] [Full Text] [Related]
3. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions. Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B. Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847 [Abstract] [Full Text] [Related]
4. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih IeM. Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578 [Abstract] [Full Text] [Related]
5. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R. Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507 [Abstract] [Full Text] [Related]
6. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R. Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863 [Abstract] [Full Text] [Related]
7. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma. Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA. Cancer; 2007 Sep 15; 110(6):1264-71. PubMed ID: 17647260 [Abstract] [Full Text] [Related]
8. Expression of seprase in effusions from patients with epithelial ovarian carcinoma. Zhang MZ, Qiao YH, Nesland JM, Trope C, Kennedy A, Chen WT, Suo ZH. Chin Med J (Engl); 2007 Apr 20; 120(8):663-8. PubMed ID: 17517181 [Abstract] [Full Text] [Related]
9. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma. Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R. Gynecol Oncol; 2004 May 20; 93(2):517-23. PubMed ID: 15099972 [Abstract] [Full Text] [Related]
10. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK, Grelewski P, Popiela A, Noga L, Rabczyñski J. Gynecol Oncol; 2004 Oct 20; 95(1):23-31. PubMed ID: 15385106 [Abstract] [Full Text] [Related]
11. [Correlation of expression of heparanase to angiogenesis and prognosis of breast cancer]. Liu ZZ, Zhang HW, Wei B, Cui SD. Ai Zheng; 2004 Nov 20; 23(11):1342-5. PubMed ID: 15522187 [Abstract] [Full Text] [Related]
12. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions. Davidson B, Dong HP, Holth A, Berner A, Risberg B. Breast J; 2008 Nov 20; 14(5):476-82. PubMed ID: 18657145 [Abstract] [Full Text] [Related]
13. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma. Davidson B, Shih IeM, Wang TL. Hum Pathol; 2008 Nov 20; 39(11):1630-6. PubMed ID: 18656238 [Abstract] [Full Text] [Related]
14. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B. Breast Cancer Res Treat; 2005 Nov 20; 94(1):71-80. PubMed ID: 16142438 [Abstract] [Full Text] [Related]
15. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R. Gynecol Oncol; 2006 Sep 20; 102(3):453-61. PubMed ID: 16494928 [Abstract] [Full Text] [Related]
16. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC. Cancer; 2004 May 15; 100(10):2139-47. PubMed ID: 15139056 [Abstract] [Full Text] [Related]
17. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B. Int J Gynecol Pathol; 2009 May 15; 28(3):211-21. PubMed ID: 19620938 [Abstract] [Full Text] [Related]
18. Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities. Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B. Diagn Cytopathol; 2005 Nov 15; 33(5):332-7. PubMed ID: 16240397 [Abstract] [Full Text] [Related]
19. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma. Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B. Hum Pathol; 2009 Jun 15; 40(6):795-806. PubMed ID: 19157506 [Abstract] [Full Text] [Related]
20. Heparanase expression in gallbladder carcinoma and its correlation to prognosis. Wu W, Pan C, Yu H, Gong H, Wang Y. J Gastroenterol Hepatol; 2008 Mar 15; 23(3):491-7. PubMed ID: 17524042 [Abstract] [Full Text] [Related] Page: [Next] [New Search]